ArticleThe Journal of experimental medicine2017

An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition.

Helen L Young et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.